title: Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint.
authors.affiliation: Department of Molecular Medicine and Surgery, Karolinska Institutet/Karolinska University Hospital, SE-17176 Stockholm, Sweden.
authors.forename: Tatja
authors.initials: T
authors.lastname: Hirvikoski
authors.forename: Anna
authors.initials: A
authors.lastname: Nordenström
authors.forename: Anna
authors.initials: A
authors.lastname: Wedell
authors.forename: Martin
authors.initials: M
authors.lastname: Ritzén
authors.forename: Svetlana
authors.initials: S
authors.lastname: Lajic
mesh_terms: D000312:Adrenal Hyperplasia, Congenital / Q000188:drug therapy* / Q000453:epidemiology; D002986:Clinical Trials as Topic; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000188:drug therapy* / Q000453:epidemiology; D012307:Risk Factors; D013548:Sweden; D014770:Virilism / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D005938:Glucocorticoids; D003907:Dexamethasone